Categories
Essays
Links
Category Archives: THE FUTURE OF PBM/LLLT
Shining a Light on PBM & The Health Care Innovation Ecosystem
By Ms. Hannah M Clark, Global NetGeneration of Youth Cyberjournalist, with support from Dr. Ronnie Lowenstein, Executive Director Global NetGeneration of Youth
Recently, I was honored to be invited by Dr. Robert Boege, Executive Director of ASTRA to join ASTRA’s Futurist Dr. Ronnie Lowenstein, and serve as a NetGeneration of Youth Cyberjournalist covering a Congressional Briefing held in the Rayburn House Office Building on October 11, 2018 entitled, “Ending Opioid Use: A New Hope”. The event was co-sponsored by ASTRA, The World Association for Laser Therapy, NetGeneration of Youth, The Optical Society of America, and thirteen other science and medical organizations. What an opportunity to learn about PBM, “photobiomodulation,” an innovative medical technology, as well as, to be exposed to the organizational stakeholders who advocate for support of America’s ‘science and technology innovation ecosystem.’
What is PBM and What does it Promise?
When I first heard the term photobiomodulation (PBM) I was confused—initially the word sounded like a … Continue reading
Posted in Industry, THE FUTURE OF PBM/LLLT
on Shining a Light on PBM & The Health Care Innovation Ecosystem
New Technologies, Treatments Can End Opioid Use
Those suffering from America’s opioid crisis recently received two major messages of hope.
On Oct. 24, President Donald Trump signed the Opioid Crisis Response Act (OCRA) into law. Dozens of bills designed to address the diverse aspects of the opioid crisis were consolidated into one strategic and integrated approach.
OCRA received overwhelming bi-partisan support in both Chambers.
HR6, which is now Public Law 115-2716, broke new ground in being the first legislation to mandate aggressive development and adoption of alternative pain treatments that include “innovative medical technologies for pain management.”
On Oct. 11, Congress held its first ever briefing on ending opioid use through “innovative medical technologies for pain management.”
Photobiomodulation (PBM) was the featured technology.
Read the full news story on newsmax.com
Posted in Industry, THE FUTURE OF PBM/LLLT
on New Technologies, Treatments Can End Opioid Use
THOR CEO leads official US Congressional Briefing on Photobiomodulation (PBM)
Washington DC, 11th October, 2018. James Carroll (CEO, THOR Photomedicine), Prof. Praveen Arany (University at Buffalo, NY), Annette Quinn RN (Program Manager, Radiation Oncology, University of Pittsburgh (UPMC) Cancer Center) introduced Photobiomodulation (PBM) to a large gathering of senior policy officials at the Rayburn House Office Building.
James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.
The briefing was a historic step for PBM, moving the conversation forward as members of congress were shown stories by members of the public on how PBM had impacted them and enabled them to live a life free from opioids.
The panel outlined the needs for PBM adoption as
- Research grants to fund further basic science experiments, therapeutic dose, and large multicenter … Continue reading
Posted in Industry, THE FUTURE OF PBM/LLLT
on THOR CEO leads official US Congressional Briefing on Photobiomodulation (PBM)
Seeing The Light
Written by Scot Faulkner
[Scot Faulkner advises global organizations and universities on healthcare reform and innovation. He served as the Chief Administrative Officer of the U.S. House of Representatives. He also served on the White House Staff, and as an Executive Branch Appointee.]
Imagine being successfully treated, painlessly and safely, for a wide range of diseases and conditions. Imagine having a cure for chronic pain.
This revolution in health and wellness is already available and will be celebrated on May 16 as the United Nations’ Annual International Day of Light.
On May 16, 1960, American physicist and engineer, Theodore Maiman, operated the first successful laser, achieving coherent and controllable light waves. This revolutionized manufacturing, communications, and health.
In 1967, Endre Mester in Semmelweis University Budapest, Hungary conducted studies to determine if lasers caused cancer. He shaved the hair from the bodies of mice, divided them into two groups and gave a laser treatment with a low powered ruby laser to one group. They did not get cancer. Instead the … Continue reading
Posted in Special Feature, THE FUTURE OF PBM/LLLT
on Seeing The Light
James Carroll SPIE 2016 interview
The LLLT / PBM world according to James Carroll, CEO of THORLaser
Posted in Industry, Interviews, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on James Carroll SPIE 2016 interview
Pubmed to adopt “Photobiomodulation Therapy” as a MeSH term
The US National Library of Medicine (NLM) plans to adopt “Photobiomodulation Therapy” (PBMT) as an official MeSH term in November 2015.
Why this is important?
Posted in THE FUTURE OF PBM/LLLT
on Pubmed to adopt “Photobiomodulation Therapy” as a MeSH term
THOR LLLT presentation at United Nations – Global Health Impact Forum
This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).